Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

 Dow Up 1.12% Nasdaq Up 1.66%
Celldex Therapeutics, Inc. (CLDX)At 1:20PM EDT: 8.85  Up 0.77 (9.53%)  
More on CLDX
Quotes
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
HereIncome Statement

Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2009Dec 31, 2008Dec 31, 2007
Total Revenue 15,180   7,456   5,103  
Cost of Revenue -   -   -  
Gross Profit 15,180   7,456   5,103  
Operating Expenses
Research Development26,169   -  18,496  
Selling General and Administrative17,119  41,095  8,502  
Non Recurring8,397  14,756   -  
Others949  361  960  
Total Operating Expenses52,634   -   -  
Operating Income or Loss (36,850) (48,756) (22,855)
Income from Continuing Operations
Total Other Income/Expenses Net852  1,255  1,096  
Earnings Before Interest And Taxes(36,602)(47,501)(21,759)
Interest Expense452   -   -  
Income Before Tax(37,054)(47,501)(21,759)
Income Tax Expense(529) -  (120)
Minority Interest -   -   -  
Net Income From Continuing Ops(36,525)(47,501)(21,639)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (36,525) (47,501) (21,639)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares ($36,525) ($47,501) ($21,639)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More